Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2023 Earnings Conference Call May 9, 2023 8:00 AM ET

Company Participants

Tiffany Aldrich - Associate Director, Corporate Communications

Sheldon Koenig - President and Chief Executive Officer

Eric Warren - Chief Commercial Officer

Benjamin Halladay - Chief Financial Officer

JoAnne Foody - Chief Medical Officer

Betty Swartz - Chief Strategy Officer

Conference Call Participants

Dennis Ding - Jefferies

Serge Belanger - Needham

Jessica Fye - JPMorgan

Jason Zemansky - Bank of America

Troy Langford - TD Cowen

Judah Frommer - Credit Suisse

Operator

Ladies and gentlemen, thank you for standing by and welcome. [Operator Instructions] Please be advised that today's conference may be recorded. I would now like to hand the conference over to Tiffany Aldrich, Associate Director, Corporate Communications, at Esperion. Please go ahead, Tiffany.

Tiffany Aldrich

Thank you. Good morning and welcome to Esperion's First Quarter 2023 Earnings Conference Call.

I want to remind callers that the information discussed on the call today is covered under the safe harbor provisions of the Private Securities Litigation Reform Act. I caution listeners that management will be making forward-looking statements. Actual results could differ materially from those stated or implied by our forward-looking statements due to risks and uncertainties associated with the business. These forward-looking statements are qualified in their entirety by the cautionary statements contained in today's press release, presentation and our SEC filings. The content of this conference call contains time-sensitive information that is accurate only as of the date of this live broadcast, May 9, 2023. We undertake no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call and webcast. As a reminder, this conference call and webcast are being recorded and archived. We issued a press release this morning detailing the contents of today's call. A copy can be found at esperion.com, within the Investors & Media section.

With us today are Sheldon Koenig, President and CEO; Ben Halladay, Chief Financial Officer; Dr. JoAnne Foody, Chief Medical Officer; Eric Warren, Chief Commercial Officer; and B.J. Swartz, Chief Strategy Officer. We will begin with prepared comments and then open the call for your questions. Following today's call, the team will be available for follow-up questions.

I'll now turn the call over to Sheldon for some prepared remarks. Sheldon?

Sheldon Koenig

Thank you, Tiffany and good morning, everyone. Thank you for joining us today to review our first quarter results and significant recent achievements.